Stockscreener 앱 받기
8.983
4.94%
0.423
시간 외 거래:
8.98
-0.003
-0.03%
Passage Bio Inc 주식(PASG)의 최신 뉴스
Lucid Capital Markets initiates Passage Bio stock with Buy rating By Investing.com - Investing.com Nigeria
Lucid Capital Markets initiates Passage Bio stock with Buy rating - Investing.com India
Will Salona Cotspin Limited Benefit From Broader Market BounceLow Risk Investment Ideas & Maximize Gains Professionally - earlytimes.in
Passage Bio (PASG) Price Target Decreased by 45.15% to 33.15 - MSN
How Passage Bio Inc. stock compares to market leadersInsider Selling & AI Powered Market Trend Analysis - newser.com
Is Passage Bio Inc. stock bottoming out2025 Volatility Report & Proven Capital Preservation Tips - newser.com
Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates - MSN
How Passage Bio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Low Risk High Win Rate Picks - newser.com
Applying chart zones and confluence areas to Passage Bio Inc.2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
What momentum shifts mean for Passage Bio Inc.July 2025 Technicals & Safe Entry Trade Reports - newser.com
Chardan Capital Expects Reduced Earnings for Passage Bio - Defense World
Passage Bio Inc. stock trendline breakdownWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Ranking Passage Bio Inc. among high performing stocks via toolsQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Passage Bio, Inc.Common Stock (NQ: PASG - FinancialContent
Using economic indicators to assess Passage Bio Inc. potentialQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
How Passage Bio Inc. stock reacts to global recession fearsEarnings Miss & Real-Time Volume Triggers - newser.com
Passage Bio Inc Stock Analysis and ForecastREITs Market Trends & Low Cost Wealth Plans - earlytimes.in
Chardan Capital Raises Passage Bio (NASDAQ:PASG) Price Target to $21.00 - Defense World
Passage Bio (NASDAQ:PASG) Price Target Raised to $21.00 - Defense World
Is Passage Bio Inc. stock a contrarian buyJuly 2025 Final Week & Weekly Stock Breakout Alerts - Fundação Cultural do Pará
What is Wedbush’s Forecast for Passage Bio FY2025 Earnings? - Defense World
Will Passage Bio Inc. price bounce be sustainableJuly 2025 Summary & Low Risk High Reward Ideas - newser.com
Why Passage Bio Inc. stock could rally in 2025Weekly Trend Recap & Stock Portfolio Risk Control - newser.com
Why Passage Bio Inc. stock remains a top recommendationEarnings Growth Report & Low Drawdown Investment Ideas - newser.com
Chardan Capital Raises Price Target on Passage Bio (PASG) to $21 - GuruFocus
Chardan Raises Price Target on Passage Bio to $21 From $6, Keeps Buy Rating - MarketScreener
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts - TipRanks
Chardan Capital Maintains Passage Bio (PASG) Buy Recommendation - MSN
Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF) and Passage Bio (PASG) - The Globe and Mail
Passage Bio Cuts Losses And Gains Analysts’ Confidence - Finimize
PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates - Nasdaq
Passage Bio (PASG) Advances PBFT02 Clinical Trials and FDA Discu - GuruFocus
[10-Q] Passage BIO, Inc. Quarterly Earnings Report | PASG SEC FilingForm 10-Q - Stock Titan
Passage Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Passage Bio Q3 net loss narrows to $7.7 mln - MarketScreener
Passage Bio, Inc. Announces Active Enrollment in upliFT-D Study and Regulatory Alignment with FDA - Quiver Quantitative
PASG: Clinical trial progress, reduced net loss, and strong cash position support future milestones - TradingView
[8-K] Passage BIO, Inc. Reports Material Event | PASG SEC FilingForm 8-K - Stock Titan
Passage Bio (NASDAQ: PASG) narrows net loss to $7.7M, y/y from $19.3M as costs decline - Stock Titan
0.53%
1.88%
자본화:
|
볼륨(24시간):